2023-06-05 08:15:00
Many eyes turned to WntResearch last year after the company presented unexpectedly positive observations from the phase II study NeoFox with Foxy-5. The observations have led the company to update the study plan and they have carried out a rights issue to finance the ongoing work. BioStock spoke to the company's co-founder, Professor Tommy Andersson, about the observations and the work ahead.
Read the full article at biostock.se (https://www.biostock.se/en/):
https://www.biostock.se/en/2023/06/co-founder-on-wntresearchs-new-neofox-findings/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se